DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
46	悪性関節リウマチ	1

告示番号

疾患名（ページ内リンク）

臨床試験数

悪性関節リウマチ

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01745055 (ClinicalTrials.gov)	April 2005	4/12/2012	Co-Administration Of Methotrexate And CP-690,550	A Phase 1, Open Label Study Of The Pharmacokinetics Of Multiple Doses Of Oral CP-690,550 And Single Doses Of Oral Methotrexate In Rheumatoid Arthritis Subjects	Rheumatoid Arthritis	Drug: CP-690,550 (tofacitinib);Drug: Methotrexate (MTX)	Pfizer	NULL	Completed	18 Years	70 Years	All	12	Phase 1	United States

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT01745055
(ClinicalTrials.gov)

April 2005

4/12/2012

Co-Administration Of Methotrexate And CP-690,550

A Phase 1, Open Label Study Of The Pharmacokinetics Of Multiple Doses Of Oral CP-690,550 And Single Doses Of Oral Methotrexate In Rheumatoid Arthritis Subjects

Rheumatoid Arthritis

Drug: CP-690,550 (tofacitinib);Drug: Methotrexate (MTX)

Pfizer

NULL

Completed

18 Years

70 Years

All

Phase 1

United States